US Stock MarketDetailed Quotes

TARS Tarsus Pharmaceuticals

Watchlist

27.140
+0.100+0.37%

Close Jul 22 16:00 ET

27.140
0.0000.00%

Post 16:20 ET

1.03BMarket Cap-5713P/E (TTM)

Tarsus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-72.00%-37.79M

-139.63%-117.49M

-261.73%-39.34M

-73.89%-32.36M

-459.43%-23.83M

-43.73%-21.97M

-1,408.16%-49.03M

10.29%-10.87M

-361.68%-18.61M

-120.72%-4.26M

Net income from continuing operations

-52.57%-35.73M

-118.86%-135.89M

-208.13%-41.9M

-73.91%-39.15M

-447.17%-31.42M

-15.72%-23.42M

-349.06%-62.09M

8.43%-13.6M

-43.41%-22.51M

-190.51%-5.74M

Operating gains losses

509.09%201K

-123.31%-117K

-794.12%-152K

105.56%37K

-113.73%-35K

-86.59%33K

-52.42%502K

92.70%-17K

-94.86%18K

-71.76%255K

Depreciation and amortization

159.62%270K

169.85%877K

254.08%347K

159.57%244K

97.83%182K

153.66%104K

4.17%325K

145.00%98K

13.25%94K

-26.40%92K

Other non cash items

6.03%246K

19.79%926K

21.61%242K

7.11%226K

15.90%226K

38.10%232K

-86.65%773K

71.55%199K

131.87%211K

343.18%195K

Change In working capital

-510.45%-8.59M

132.18%306K

-3,402.35%-2.81M

3,093.18%1.41M

214.90%3.12M

-186.27%-1.41M

-169.31%-951K

129.73%85K

-99.78%44K

-126.22%-2.71M

-Change in receivables

-2,152.18%-13.65M

-304.90%-14.13M

-2,744.06%-11.34M

-80.54%-6.12M

1,037.19%2.67M

374.79%665K

-4,680.82%-3.49M

832.61%429K

-116.94%-3.39M

-102.32%-285K

-Change in inventory

---929K

---3.11M

---3.09M

----

--0

----

-Change in prepaid assets

314.40%1.07M

-300.69%-2.89M

-46.31%-1.86M

-198.51%-793K

58.31%-492K

-72.25%257K

64.71%-721K

7.83%-1.27M

-6.83%805K

2.16%-1.18M

-Change in payables and accrued expense

313.99%5.05M

491.93%20.97M

1,163.90%13.41M

219.13%8.41M

233.66%1.51M

-341.70%-2.36M

-37.18%3.54M

16.72%1.06M

915.48%2.63M

-428.20%-1.13M

-Change in other current assets

178.95%106K

-233.95%-718K

21.43%-110K

---102K

-511.24%-544K

171.43%38K

90.51%-215K

-128.17%-140K

--0

91.69%-89K

-Change in other current liabilities

-2,800.00%-232K

376.12%185K

2,600.00%189K

1,200.00%33K

-3.57%-29K

81.40%-8K

-158.26%-67K

120.00%7K

-106.98%-3K

-75.00%-28K

Cash from discontinued investing activities

Operating cash flow

-72.00%-37.79M

-139.63%-117.49M

-261.73%-39.34M

-73.89%-32.36M

-459.43%-23.83M

-43.73%-21.97M

-1,408.16%-49.03M

10.29%-10.87M

-361.68%-18.61M

-120.72%-4.26M

Investing cash flow

Cash flow from continuing investing activities

-1,005.12%-102.22M

197.22%140.6M

120.47%17.85M

182.92%47.37M

52,634.43%64.09M

7,114.91%11.29M

-24,580.72%-144.63M

-31,731.75%-87.22M

-47,112.40%-57.13M

-662.50%-122K

Net PPE purchase and sale

48.82%-174K

-196.84%-1.5M

--0

-290.63%-375K

-545.08%-787K

-111.18%-340K

13.65%-506K

53.65%-127K

20.66%-96K

-662.50%-122K

Net intangibles purchase and sale

----

---4M

--0

----

--0

----

Net investment purchase and sale

-977.17%-102.05M

201.38%146.11M

120.50%17.85M

190.73%51.74M

--64.88M

--11.63M

---144.12M

---87.09M

---57.03M

--0

Cash from discontinued investing activities

Investing cash flow

-1,005.12%-102.22M

197.22%140.6M

120.47%17.85M

182.92%47.37M

52,634.43%64.09M

7,114.91%11.29M

-24,580.72%-144.63M

-31,731.75%-87.22M

-47,112.40%-57.13M

-662.50%-122K

Financing cash flow

Cash flow from continuing financing activities

2,069.78%108.77M

38.50%130.18M

7,384.85%19.76M

77,227.21%104.89M

-99.32%510K

-73.79%5.01M

447,457.14%93.99M

456.76%264K

-281.33%-136K

7,473,300.00%74.73M

Net issuance payments of debt

--0

-50.00%10M

--0

--5M

--0

-75.00%5M

--20M

--0

Net common stock issuance

--107.97M

59.51%118.6M

--19.22M

45,685.78%99.38M

--0

--74.35M

--0

---218K

----

Proceeds from stock option exercised by employees

6,069.23%802K

169.57%1.58M

103.79%538K

529.27%516K

113.39%510K

--13K

80.56%585K

15.28%264K

9.33%82K

23,800.00%239K

Net other financing activities

----

-213.53%-950K

--0

---75K

Cash from discontinued financing activities

Financing cash flow

2,069.78%108.77M

38.50%130.18M

7,384.85%19.76M

77,227.21%104.89M

-99.32%510K

-73.79%5.01M

447,457.14%93.99M

456.76%264K

-281.33%-136K

7,473,300.00%74.73M

Net cash flow

Beginning cash position

213.91%224.95M

-58.17%71.66M

33.74%226.67M

-56.48%106.77M

-62.29%66M

-58.17%71.66M

1.89%171.33M

-7.79%169.49M

38.83%245.36M

12.04%175.01M

Current changes in cash

-451.69%-31.24M

253.79%153.29M

98.24%-1.73M

258.02%119.9M

-42.04%40.78M

-253.97%-5.66M

-3,231.39%-99.67M

-684.58%-97.83M

-1,173.79%-75.87M

242.58%70.35M

End cash Position

193.51%193.71M

213.91%224.95M

33.74%226.67M

-56.48%106.77M

-62.29%66M

-58.17%71.66M

-7.79%169.49M

38.83%245.36M

Free cash flow

-70.16%-37.96M

-148.29%-123M

-257.56%-39.34M

-96.38%-36.74M

-461.81%-24.61M

-44.43%-22.31M

-1,666.60%-49.54M

11.25%-11M

-367.59%-18.71M

-121.33%-4.38M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-72.00%-37.79M	-139.63%-117.49M	-261.73%-39.34M	-73.89%-32.36M	-459.43%-23.83M	-43.73%-21.97M	-1,408.16%-49.03M	10.29%-10.87M	-361.68%-18.61M	-120.72%-4.26M
Net income from continuing operations	-52.57%-35.73M	-118.86%-135.89M	-208.13%-41.9M	-73.91%-39.15M	-447.17%-31.42M	-15.72%-23.42M	-349.06%-62.09M	8.43%-13.6M	-43.41%-22.51M	-190.51%-5.74M
Operating gains losses	509.09%201K	-123.31%-117K	-794.12%-152K	105.56%37K	-113.73%-35K	-86.59%33K	-52.42%502K	92.70%-17K	-94.86%18K	-71.76%255K
Depreciation and amortization	159.62%270K	169.85%877K	254.08%347K	159.57%244K	97.83%182K	153.66%104K	4.17%325K	145.00%98K	13.25%94K	-26.40%92K
Other non cash items	6.03%246K	19.79%926K	21.61%242K	7.11%226K	15.90%226K	38.10%232K	-86.65%773K	71.55%199K	131.87%211K	343.18%195K
Change In working capital	-510.45%-8.59M	132.18%306K	-3,402.35%-2.81M	3,093.18%1.41M	214.90%3.12M	-186.27%-1.41M	-169.31%-951K	129.73%85K	-99.78%44K	-126.22%-2.71M
-Change in receivables	-2,152.18%-13.65M	-304.90%-14.13M	-2,744.06%-11.34M	-80.54%-6.12M	1,037.19%2.67M	374.79%665K	-4,680.82%-3.49M	832.61%429K	-116.94%-3.39M	-102.32%-285K
-Change in inventory	---929K	---3.11M	---3.09M	----	----	--0	--0	--0	----	----
-Change in prepaid assets	314.40%1.07M	-300.69%-2.89M	-46.31%-1.86M	-198.51%-793K	58.31%-492K	-72.25%257K	64.71%-721K	7.83%-1.27M	-6.83%805K	2.16%-1.18M
-Change in payables and accrued expense	313.99%5.05M	491.93%20.97M	1,163.90%13.41M	219.13%8.41M	233.66%1.51M	-341.70%-2.36M	-37.18%3.54M	16.72%1.06M	915.48%2.63M	-428.20%-1.13M
-Change in other current assets	178.95%106K	-233.95%-718K	21.43%-110K	---102K	-511.24%-544K	171.43%38K	90.51%-215K	-128.17%-140K	--0	91.69%-89K
-Change in other current liabilities	-2,800.00%-232K	376.12%185K	2,600.00%189K	1,200.00%33K	-3.57%-29K	81.40%-8K	-158.26%-67K	120.00%7K	-106.98%-3K	-75.00%-28K
Cash from discontinued investing activities
Operating cash flow	-72.00%-37.79M	-139.63%-117.49M	-261.73%-39.34M	-73.89%-32.36M	-459.43%-23.83M	-43.73%-21.97M	-1,408.16%-49.03M	10.29%-10.87M	-361.68%-18.61M	-120.72%-4.26M
Investing cash flow
Cash flow from continuing investing activities	-1,005.12%-102.22M	197.22%140.6M	120.47%17.85M	182.92%47.37M	52,634.43%64.09M	7,114.91%11.29M	-24,580.72%-144.63M	-31,731.75%-87.22M	-47,112.40%-57.13M	-662.50%-122K
Net PPE purchase and sale	48.82%-174K	-196.84%-1.5M	--0	-290.63%-375K	-545.08%-787K	-111.18%-340K	13.65%-506K	53.65%-127K	20.66%-96K	-662.50%-122K
Net intangibles purchase and sale	----	---4M	--0	----	----	----	--0	--0	----	----
Net investment purchase and sale	-977.17%-102.05M	201.38%146.11M	120.50%17.85M	190.73%51.74M	--64.88M	--11.63M	---144.12M	---87.09M	---57.03M	--0
Cash from discontinued investing activities
Investing cash flow	-1,005.12%-102.22M	197.22%140.6M	120.47%17.85M	182.92%47.37M	52,634.43%64.09M	7,114.91%11.29M	-24,580.72%-144.63M	-31,731.75%-87.22M	-47,112.40%-57.13M	-662.50%-122K
Financing cash flow
Cash flow from continuing financing activities	2,069.78%108.77M	38.50%130.18M	7,384.85%19.76M	77,227.21%104.89M	-99.32%510K	-73.79%5.01M	447,457.14%93.99M	456.76%264K	-281.33%-136K	7,473,300.00%74.73M
Net issuance payments of debt	--0	-50.00%10M	--0	--5M	--0	-75.00%5M	--20M	--0	--0	--0
Net common stock issuance	--107.97M	59.51%118.6M	--19.22M	45,685.78%99.38M	--0	--0	--74.35M	--0	---218K	----
Proceeds from stock option exercised by employees	6,069.23%802K	169.57%1.58M	103.79%538K	529.27%516K	113.39%510K	--13K	80.56%585K	15.28%264K	9.33%82K	23,800.00%239K
Net other financing activities	----	----	----	----	----	----	-213.53%-950K	--0	--0	---75K
Cash from discontinued financing activities
Financing cash flow	2,069.78%108.77M	38.50%130.18M	7,384.85%19.76M	77,227.21%104.89M	-99.32%510K	-73.79%5.01M	447,457.14%93.99M	456.76%264K	-281.33%-136K	7,473,300.00%74.73M
Net cash flow
Beginning cash position	213.91%224.95M	-58.17%71.66M	33.74%226.67M	-56.48%106.77M	-62.29%66M	-58.17%71.66M	1.89%171.33M	-7.79%169.49M	38.83%245.36M	12.04%175.01M
Current changes in cash	-451.69%-31.24M	253.79%153.29M	98.24%-1.73M	258.02%119.9M	-42.04%40.78M	-253.97%-5.66M	-3,231.39%-99.67M	-684.58%-97.83M	-1,173.79%-75.87M	242.58%70.35M
End cash Position	193.51%193.71M	213.91%224.95M	213.91%224.95M	33.74%226.67M	-56.48%106.77M	-62.29%66M	-58.17%71.66M	-58.17%71.66M	-7.79%169.49M	38.83%245.36M
Free cash flow	-70.16%-37.96M	-148.29%-123M	-257.56%-39.34M	-96.38%-36.74M	-461.81%-24.61M	-44.43%-22.31M	-1,666.60%-49.54M	11.25%-11M	-367.59%-18.71M	-121.33%-4.38M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall